Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

Autoencoder Imputation of Missing Heterogeneous Data for Alzheimer's Disease Classification

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

Classification of Alzheimer's Disease Based on Stacked Denoising Autoencoder

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data

Deep Neural Network Classifier for Alzheimer’s Disease

Alzheimer's Disease Classification Confidence of Individuals using Deep Learning on Heterogeneous Data

Multi-task deep autoencoder to predict Alzheimer's disease progression using temporal DNA methylation data in peripheral blood

Deep Learning for Alzheimer's Disease Prediction: A Comprehensive Review

An Accurate Prediction and Diagnosis of Alzheimer’s Disease using Deep Learning

Incomplete multi-modal representation learning for Alzheimer's disease diagnosis

Development of hybrid deep CNN with denoising MLP for accurate prediction of Alzheimer's disease

Addressing the missing data challenge in multi-modal datasets for the diagnosis of Alzheimer’s disease

Multimodal Alzheimer's disease classification through ensemble deep random vector functional link neural network

Autoencoder to Identify Sex-Specific Sub-phenotypes in Alzheimer's Disease Progression Using Longitudinal Electronic Health Records

Prediction and clustering of Alzheimer's disease by race and sex: a multi-head deep-learning approach to analyze irregular and heterogeneous data

Early Diagnosis of Alzheimer's Disease Based on Resting-State Brain Networks and Deep Learning

Multimodal deep learning for Alzheimer’s disease dementia assessment

Dual Attention Convolutional AutoEncoder for Diagnosis of Alzheimer's Disorder in Patients Using Neuroimaging and MRI Features

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

Deep Learning-Based Prediction of Alzheimer's Disease Using Microarray Gene Expression Data